Benvenga S - Search Results

1

Vita R, Mazzi V, Antonelli A, Benvenga S. Vita R, et al. Among authors: benvenga s. Expert Opin Drug Saf. 2013 Nov;12(6):865-72. doi: 10.1517/14740338.2013.823397. Epub 2013 Jul 25. Expert Opin Drug Saf. 2013. PMID: 23883069 Review.

2

Radioimmunoassay for human thyroxine-binding prealbumin.

Benvenga S, Bartalena L, Antonelli A, Li Calzi L, Di Pasquale G, Trimarchi F, Pinchera A. Benvenga S, et al. Ann Clin Lab Sci. 1986 May-Jun;16(3):231-40. Ann Clin Lab Sci. 1986. PMID: 3087265

3

A patient with stress-related onset and exacerbations of Graves disease.

Vita R, Lapa D, Vita G, Trimarchi F, Benvenga S. Vita R, et al. Among authors: benvenga s. Nat Clin Pract Endocrinol Metab. 2009 Jan;5(1):55-61. doi: 10.1038/ncpendmet1006. Epub 2008 Nov 25. Nat Clin Pract Endocrinol Metab. 2009. PMID: 19029994

4

Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists.

Antonelli A, Ferrari SM, Fallahi P, Frascerra S, Piaggi S, Gelmini S, Lupi C, Minuto M, Berti P, Benvenga S, Basolo F, Orlando C, Miccoli P. Antonelli A, et al. Among authors: benvenga s. Endocr Relat Cancer. 2009 Dec;16(4):1299-311. doi: 10.1677/ERC-08-0337. Epub 2009 Sep 15. Endocr Relat Cancer. 2009. PMID: 19755523

5

HLA haplotype in a patient with systemic lupus erythematosus triggered by hepatitis B vaccine.

Santoro D, Vita G, Vita R, Mallamace A, Savica V, Bellinghieri G, Benvenga S, Gangemi S. Santoro D, et al. Among authors: benvenga s. Clin Nephrol. 2010 Aug;74(2):150-3. doi: 10.5414/cnp74150. Clin Nephrol. 2010. PMID: 20630136

6

Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease.

Antonelli A, Ferrari SM, Frascerra S, Corrado A, Pupilli C, Bernini G, Benvenga S, Ferrannini E, Fallahi P. Antonelli A, et al. Among authors: benvenga s. Exp Cell Res. 2011 Jul 1;317(11):1527-33. doi: 10.1016/j.yexcr.2011.04.007. Epub 2011 Apr 30. Exp Cell Res. 2011. PMID: 21565188

7

Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10.

Antonelli A, Ferrari SM, Frascerra S, Galetta F, Franzoni F, Corrado A, Miccoli M, Benvenga S, Paolicchi A, Ferrannini E, Fallahi P. Antonelli A, et al. Among authors: benvenga s. Cytokine. 2011 Aug;55(2):288-93. doi: 10.1016/j.cyto.2011.04.022. Epub 2011 May 20. Cytokine. 2011. PMID: 21601475

8

A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations.

Vita R, Saraceno G, Trimarchi F, Benvenga S. Vita R, et al. Among authors: benvenga s. Endocrine. 2013 Feb;43(1):154-60. doi: 10.1007/s12020-012-9772-2. Epub 2012 Aug 30. Endocrine. 2013. PMID: 22932947 Clinical Trial.

9

Autoimmune thyroid disease elicited by NY-ESO-1 vaccination.

Vita R, Guarneri F, Agah R, Benvenga S. Vita R, et al. Among authors: benvenga s. Thyroid. 2014 Feb;24(2):390-4. doi: 10.1089/thy.2013.0170. Epub 2013 Jul 25. Thyroid. 2014. PMID: 23590991 Free PMC article.

10

Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10.

Antonelli A, Fallahi P, Ferrari SM, Colaci M, Giuggioli D, Saraceno G, Benvenga S, Ferri C. Antonelli A, et al. Among authors: benvenga s. J Interferon Cytokine Res. 2013 Dec;33(12):739-45. doi: 10.1089/jir.2012.0091. Epub 2013 Jul 31. J Interferon Cytokine Res. 2013. PMID: 23902475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

376 results

Search Page

Filters